Skip to main content
TipRanks
Go Ultimate75% OFF

Luke Beshar Insider Profile

11 Followers

Luke Beshar, Director at Protara Therapeutics, holds 198.00K shares in Protara Therapeutics (Ticker: TARA), holds 0.00 shares in RegenXBio (Ticker: RGNX), holds 0.00 shares in NPS Pharma (Ticker: NPSP). Most recently, Luke Beshar Bought ― shares of Protara Therapeutics on Jul 05, 2022 for an estimated value of $31.00K.

Luke Beshar's Trading History

TARA
Protara Therapeutics
Jul 05, 2022DirectorInformative Buy31.00K$500.94K
RGNX
RegenXBio
Dec 03, 2018DirectorUninformative Buy48.07K$0.00
NPSP
NPS Pharma
Feb 24, 2015―Uninformative Sell3.46M―
CBM
Cambrex
―――$0.00
OMGAQ
Omega Therapeutics
――――

You May Also Like

Luke Beshar insider profile FAQ

What is the percentage of profitable transactions made by Luke Beshar?
The percentage of profitable transactions made by Luke Beshar is 0%.
What is the average return per transaction made by Luke Beshar?
The average return per transaction made by Luke Beshar is -26.80%.
What stocks does Luke Beshar hold?
Luke Beshar holds: TARA, NPSP, RGNX, OMGAQ, CBM stocks.
What was Luke Beshar’s latest transaction?
Luke Beshar’s latest transaction was an Informative Buy of $31.00K.
What was Luke Beshar's most profitable transaction?
Luke Beshar’s most profitable transaction was an Informative Buy of TARA stock on July 5, 2022. The return on the trade was -21.70%.
What is Luke Beshar's role in Protara Therapeutics?
Luke Beshar's role in Protara Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.